CAPRICOR THERAPEUTICS, INC. (CAPR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, CAPRICOR THERAPEUTICS, INC. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $355.95M in total assets against $50.16M in total liabilities.
Key ratios (FY2025)
-34.4%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.27M | $25.18M | $2.55M | $244.9K | $310.2K | $1.01M | $1.67M | $2.67M | $4.00M |
| Operating Income | -$108.14M | -$42.56M | -$24.08M | -$29.70M | -$20.94M | -$13.69M | -$7.73M | -$15.33M | -$12.86M | -$16.98M |
| Net Income | -$105.04M | -$40.47M | -$22.29M | -$29.02M | -$20.02M | -$13.66M | -$7.64M | -$15.19M | $2.43M | -$18.81M |
| EPS (Diluted) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | — | $-0.52 | $0.09 | $-1.01 |
| Total Assets | $355.95M | $170.48M | $58.73M | $50.09M | $41.33M | $34.62M | $11.11M | $9.25M | $16.27M | $18.75M |
| Total Liabilities | $50.16M | $25.02M | $36.13M | $38.31M | $9.96M | $6.42M | $4.27M | $4.63M | $5.05M | $22.75M |
| Shareholders' Equity | $305.79M | $145.46M | $22.60M | $11.79M | $31.37M | $28.20M | $6.84M | $4.62M | $11.23M | -$4.00M |
| Cash & Equivalents | $287.85M | $11.29M | $14.69M | $9.60M | $34.89M | $32.67M | $3.90M | $4.26M | $6.14M | $3.20M |
| Operating Cash Flow | -$69.81M | -$40.00M | -$25.60M | $4.92M | -$16.81M | -$10.05M | -$6.82M | -$13.86M | -$14.23M | -$14.45M |
| Capital Expenditures | $2.90M | $1.17M | $1.31M | $2.00M | $1.20M | $547.6K | $0 | $316.5K | $32.2K | $192.0K |
| Shares Outstanding | 57.37M | 45.58M | 31.15M | 25.24M | 24.19M | 20.58M | 5.23M | 3.14M | 26.27M | 21.40M |